The effects of cyclosporine and α-difluoromethylornithine on the induction of ornithine decarboxylase activity in colon cancer cells in vitro

R. Saydjari, Courtney Townsend, S. C. Barranco, A. E. Ahmed, J. C. Thompson

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Previous studies in our laboratory have demonstrated that cyclosporine (CsA) and α-difluoromethylornithine (DFMO) inhibit the growth of mouse (MC-26) colon carcinoma in vitro and in vivo. The mechanism of DFMO inhibition is known; however, the mechanism by which CsA acts remains unclear. Enzyme kinetic studies failed to demonstrate a direct effect of CsA on ODC activity; DFMO, as expected, caused significant inhibition of ODC activity. Significant induction of ODC activity occurred in MC-26 cells six hours after replating in fresh media, as compared with baseline activity obtained immediately after trypsinization. There was a super-induction of ODC activity at six hours caused by the addition of CsA (8.3 x 10-3 mM). The increase in ODC activity was effectively abolished by the addition of emetine but not actinomycin D. These findings suggest that new protein synthesis is required for the elaboration of ODC induction measured at six hours. The presence of CsA (8.3 x 10-3 mM) did not significantly alter ODC activity at 24 hours. However, both emetine and actinomycin D significantly inhibited ODC activity at 24 hours. These data indicate that the synthesis of new mRNA and subsequently new protein are required to maintain the increases in ODC activity that were observed six hours after replating.

Original languageEnglish (US)
Pages (from-to)87-95
Number of pages9
JournalClinical Chemistry and Enzymology Communications
Volume2
Issue number2
StatePublished - 1990

Fingerprint

Eflornithine
Ornithine Decarboxylase
Emetine
Colonic Neoplasms
Cyclosporine
Cells
Dactinomycin
Enzyme kinetics
Colon
Proteins
Carcinoma
Messenger RNA
Enzymes
Growth
In Vitro Techniques

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

The effects of cyclosporine and α-difluoromethylornithine on the induction of ornithine decarboxylase activity in colon cancer cells in vitro. / Saydjari, R.; Townsend, Courtney; Barranco, S. C.; Ahmed, A. E.; Thompson, J. C.

In: Clinical Chemistry and Enzymology Communications, Vol. 2, No. 2, 1990, p. 87-95.

Research output: Contribution to journalArticle

@article{ff1aa7c599394bf6a4ade4686a0d6a8e,
title = "The effects of cyclosporine and α-difluoromethylornithine on the induction of ornithine decarboxylase activity in colon cancer cells in vitro",
abstract = "Previous studies in our laboratory have demonstrated that cyclosporine (CsA) and α-difluoromethylornithine (DFMO) inhibit the growth of mouse (MC-26) colon carcinoma in vitro and in vivo. The mechanism of DFMO inhibition is known; however, the mechanism by which CsA acts remains unclear. Enzyme kinetic studies failed to demonstrate a direct effect of CsA on ODC activity; DFMO, as expected, caused significant inhibition of ODC activity. Significant induction of ODC activity occurred in MC-26 cells six hours after replating in fresh media, as compared with baseline activity obtained immediately after trypsinization. There was a super-induction of ODC activity at six hours caused by the addition of CsA (8.3 x 10-3 mM). The increase in ODC activity was effectively abolished by the addition of emetine but not actinomycin D. These findings suggest that new protein synthesis is required for the elaboration of ODC induction measured at six hours. The presence of CsA (8.3 x 10-3 mM) did not significantly alter ODC activity at 24 hours. However, both emetine and actinomycin D significantly inhibited ODC activity at 24 hours. These data indicate that the synthesis of new mRNA and subsequently new protein are required to maintain the increases in ODC activity that were observed six hours after replating.",
author = "R. Saydjari and Courtney Townsend and Barranco, {S. C.} and Ahmed, {A. E.} and Thompson, {J. C.}",
year = "1990",
language = "English (US)",
volume = "2",
pages = "87--95",
journal = "Clinical Chemistry and Enzymology Communications",
issn = "0892-2187",
publisher = "Harwood Academic Publishers",
number = "2",

}

TY - JOUR

T1 - The effects of cyclosporine and α-difluoromethylornithine on the induction of ornithine decarboxylase activity in colon cancer cells in vitro

AU - Saydjari, R.

AU - Townsend, Courtney

AU - Barranco, S. C.

AU - Ahmed, A. E.

AU - Thompson, J. C.

PY - 1990

Y1 - 1990

N2 - Previous studies in our laboratory have demonstrated that cyclosporine (CsA) and α-difluoromethylornithine (DFMO) inhibit the growth of mouse (MC-26) colon carcinoma in vitro and in vivo. The mechanism of DFMO inhibition is known; however, the mechanism by which CsA acts remains unclear. Enzyme kinetic studies failed to demonstrate a direct effect of CsA on ODC activity; DFMO, as expected, caused significant inhibition of ODC activity. Significant induction of ODC activity occurred in MC-26 cells six hours after replating in fresh media, as compared with baseline activity obtained immediately after trypsinization. There was a super-induction of ODC activity at six hours caused by the addition of CsA (8.3 x 10-3 mM). The increase in ODC activity was effectively abolished by the addition of emetine but not actinomycin D. These findings suggest that new protein synthesis is required for the elaboration of ODC induction measured at six hours. The presence of CsA (8.3 x 10-3 mM) did not significantly alter ODC activity at 24 hours. However, both emetine and actinomycin D significantly inhibited ODC activity at 24 hours. These data indicate that the synthesis of new mRNA and subsequently new protein are required to maintain the increases in ODC activity that were observed six hours after replating.

AB - Previous studies in our laboratory have demonstrated that cyclosporine (CsA) and α-difluoromethylornithine (DFMO) inhibit the growth of mouse (MC-26) colon carcinoma in vitro and in vivo. The mechanism of DFMO inhibition is known; however, the mechanism by which CsA acts remains unclear. Enzyme kinetic studies failed to demonstrate a direct effect of CsA on ODC activity; DFMO, as expected, caused significant inhibition of ODC activity. Significant induction of ODC activity occurred in MC-26 cells six hours after replating in fresh media, as compared with baseline activity obtained immediately after trypsinization. There was a super-induction of ODC activity at six hours caused by the addition of CsA (8.3 x 10-3 mM). The increase in ODC activity was effectively abolished by the addition of emetine but not actinomycin D. These findings suggest that new protein synthesis is required for the elaboration of ODC induction measured at six hours. The presence of CsA (8.3 x 10-3 mM) did not significantly alter ODC activity at 24 hours. However, both emetine and actinomycin D significantly inhibited ODC activity at 24 hours. These data indicate that the synthesis of new mRNA and subsequently new protein are required to maintain the increases in ODC activity that were observed six hours after replating.

UR - http://www.scopus.com/inward/record.url?scp=0025068759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025068759&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0025068759

VL - 2

SP - 87

EP - 95

JO - Clinical Chemistry and Enzymology Communications

JF - Clinical Chemistry and Enzymology Communications

SN - 0892-2187

IS - 2

ER -